These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 15120038

  • 1. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
    Kelland LR.
    Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
    [Abstract] [Full Text] [Related]

  • 2. 50 years of preclinical anticancer drug screening: empirical to target-driven approaches.
    Suggitt M, Bibby MC.
    Clin Cancer Res; 2005 Feb 01; 11(3):971-81. PubMed ID: 15709162
    [Abstract] [Full Text] [Related]

  • 3. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
    Voskoglou-Nomikos T, Pater JL, Seymour L.
    Clin Cancer Res; 2003 Sep 15; 9(11):4227-39. PubMed ID: 14519650
    [Abstract] [Full Text] [Related]

  • 4. The hollow fibre model in cancer drug screening: the NCI experience.
    Decker S, Hollingshead M, Bonomi CA, Carter JP, Sausville EA.
    Eur J Cancer; 2004 Apr 15; 40(6):821-6. PubMed ID: 15120037
    [Abstract] [Full Text] [Related]

  • 5. Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development.
    Peterson JK, Houghton PJ.
    Eur J Cancer; 2004 Apr 15; 40(6):837-44. PubMed ID: 15120039
    [Abstract] [Full Text] [Related]

  • 6. [Predictability of preclinical evaluation of anticancer drugs by human gastrointestinal cancer--nude mouse panel].
    Fujita M, Fujita F, Sakamoto Y, Sugimoto T, Shimozuma K, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Jul 15; 18(9):1429-37. PubMed ID: 1854213
    [Abstract] [Full Text] [Related]

  • 7. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M, Benzo A, Irrissuto C, Lopez G, Curatella B, Maggi CA, Manzini S, Crea A, Caroli S, Cubadda F, Binaschi M.
    Cancer Chemother Pharmacol; 2008 Sep 15; 62(4):621-9. PubMed ID: 18038274
    [Abstract] [Full Text] [Related]

  • 8. Chemoinformatic analysis of NCI preclinical tumor data: evaluating compound efficacy from mouse xenograft data, NCI-60 screening data, and compound descriptors.
    Wallqvist A, Huang R, Covell DG.
    J Chem Inf Model; 2007 Sep 15; 47(4):1414-27. PubMed ID: 17555311
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
    Man S, Munoz R, Kerbel RS.
    Cancer Metastasis Rev; 2007 Dec 15; 26(3-4):737-47. PubMed ID: 17846863
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nonresponsiveness of the metastatic human lung carcinoma MV522 xenograft to conventional anticancer agents.
    Kelner MJ, McMorris TC, Estes L, Starr R, Samson K, Varki N, Taetle R.
    Anticancer Res; 1995 Dec 15; 15(3):867-71. PubMed ID: 7645973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.